相关实验视频
Updated: May 24, 2025
07:27
Olfactory Assays for Mouse Models of Neurodegenerative Disease
Published on: August 25, 2014
21.9K
在帕金森病中,嗅球中存在COMT功能障碍的证据
Leah C Beauchamp1,2, Laura J Ellett2, Sydney M A Juan2
1Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Acta neuropathologica
|March 2, 2025
概括
帕金森病患者由于嗅觉球中的多巴胺代谢发生变化而经历嗅觉丧失. 降低的甲基转移酶活动增加多巴胺,损害嗅觉处理,哈洛佩里多尔在小鼠中暂时逆转了这种情况.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 病理生理学 病理生理学
背景情况:
- 缺血症是帕金森病 (PD) 的常见早期非运动症状,通常在运动症状之前几年.
- 在PD中驱动嗅觉功能障碍的精确机制在很大程度上是未知的.
- 多巴胺在嗅觉处理中的作用及其在PD中改变的代谢是正在积极研究的领域.
研究的目的:
- 研究多巴胺代谢在帕金森病患者的嗅球中的作用.
- 探索catechol-O-methyltransferase (COMT) 活性,多巴胺水平和PD中的低血之间的关系.
- 在与PD相关的嗅觉缺陷的小鼠模型中测试调节多巴胺信号的治疗潜力.
主要方法:
- 使用免疫组织化学,HPLC,西斑和ELISA分析PD和对照对象的死后嗅球组织.
- 测量氨酸氧酶 (TH) 表达和甲基转移酶 (COMT) 活性.
- 用D2受体抗剂 (haloperidol) 进行药理干预,用于低血压的淘汰赛小鼠.
主要成果:
- 在PD嗅球中观察到氨酸氧酶阳性神经元的增加,与中脑发现形成鲜明对比.
- 降低了甲基转移酶 (COMT) 的活性,降低了多巴胺转化为同酸 (HVA) 的PD嗅觉球.
- 有证据表明,S-adenosyl metionin (SAM) 的潜在耗尽是减少COMT活动的原因.
- 服用哈洛佩里多尔暂时改善了tau淘汰小鼠的嗅觉功能.
结论:
- 改变多巴胺代谢,特别是减少COMT活性,与帕金森病相关的低血有关.
- 增加多巴胺水平可能导致D2受体过度刺激,抑制嗅觉处理.
- 针对COMT介导的多巴胺通路或D2受体可能为PD早期嗅觉功能障碍提供治疗策略.
相关概念视频
01:24Parkinson's Disease: Treatment
182
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
182
01:37Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
01:15Parkinson's Disease: Overview
419
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
419